Longitudinal Analysis of Raltegravir Susceptibility and Integrase Replication Capacity of Human Immunodeficiency Virus Type 1 during Virologic Failure

We characterized the raltegravir (RAL) susceptibility and the integrase (IN)-mediated replication capacity (RC) of RAL-resistant human immunodeficiency virus type 1 from two patients experiencing virologic failure during continuous RAL salvage therapy. The following two distinct outcomes were observ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fransen, Signe, Karmochkine, Marina, Huang, Wei, Weiss, Laurence, Petropoulos, Christos J., Charpentier, Charlotte
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2009
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2764161/
https://ncbi.nlm.nih.gov/pubmed/19667293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00651-09
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars